If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 645.00
Bid: 640.00
Ask: 665.00
Change: -2.50 (-0.38%)
Spread: 25.00 (3.906%)
Open: 670.00
High: 670.00
Low: 645.00
Prev. Close: 655.00
VP. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

29 Jul 2022 10:13

RNS Number : 2558U
Singer Capital Markets Sec Ltd
29 July 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities LTD

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vp PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Vp PLC

(d) Date dealing undertaken:

28 July 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Purchase

 

2,124

 

877p

 

877p

 

ORD 5P

 

 

Sale

 

2,124

 

877p

 

877p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

29 July 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUKAKRUOUBURR
Date   Source Headline
4th Dec 20197:00 amRNSInterim Results
1st Oct 20197:00 amRNSTrading Update and Notice of Interim Results
25th Jul 201911:45 amRNSResult of Annual General Meeting
25th Jul 20197:00 amRNSAGM Statement
5th Jul 20199:17 amRNSDirector/PDMR Shareholding
25th Jun 20197:00 amRNSAnnual Report, Notice of AGM & Form of Proxy
4th Jun 20197:00 amRNSPreliminary Results (unaudited)
10th May 20197:00 amRNSAcquisition
9th Apr 20197:20 amRNSStatement re. CMA provisional findings
8th Apr 20197:00 amRNSTrading Update and Notice of Final Results
27th Nov 20187:00 amRNSInterim Results
13th Nov 20183:53 pmRNSDirector/PDMR Shareholding
13th Nov 20183:50 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Update and Notice of Interim Results
21st Aug 201810:02 amRNSVp plc AGM 2 Aug 2018 Special Business Resolution
9th Aug 20182:38 pmRNSHolding(s) in Company
2nd Aug 201812:52 pmRNSResult of Annual General Meeting
2nd Aug 20187:00 amRNSAGM Statement
4th Jul 20184:23 pmRNSDirector/PDMR Shareholding
27th Jun 20187:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20187:00 amRNSFinal Results
6th Apr 20187:00 amRNSTrading Update and Notice of Final Results
7th Mar 20185:00 pmRNSCMA clearance of the acquisition of Brandon Hire
4th Dec 20172:46 pmRNSHalf-year Report
4th Dec 20177:00 amRNSCMA investigation into Brandon Hire acquisition
28th Nov 201711:18 amRNSHolding(s) in Company
21st Nov 20177:00 amRNSInterim Results
8th Nov 20177:00 amRNSAcquisition of Brandon Hire Group Holdings Limited
23rd Oct 20173:45 pmRNSDirector/PDMR Shareholding
23rd Oct 20173:42 pmRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSTrading Update and Notice of Interim Results
22nd Aug 20174:12 pmRNSDirector/PDMR Shareholding
10th Aug 20179:24 amRNSDirector/PDMR Shareholding
2nd Aug 201711:13 amRNSVp plc AGM 1 Aug 2017 Special Business Resolution
1st Aug 20172:30 pmRNSAGM Statement
26th Jun 201711:30 amRNSAnnual Report and Notice of Annual General Meeting
6th Jun 201712:02 pmRNSPrice Monitoring Extension
6th Jun 20177:00 amRNSFinal Results
11th May 20177:00 amRNSDirector Update
25th Apr 20177:00 amRNSAcquisition and Notice of Final Results
7th Apr 20177:00 amRNSAcquisition and Trading Update
12th Dec 20162:31 pmRNSHalf-year Report
29th Nov 20167:00 amRNSInterim Results
25th Nov 20167:00 amRNSAcquisition of TechRentals NZ Ltd
21st Oct 20169:58 amRNSDirector/PDMR Shareholding
21st Oct 20169:53 amRNSDirector/PDMR Shareholding
4th Oct 20164:35 pmRNSPrice Monitoring Extension
28th Sep 20167:00 amRNSTrading Update
2nd Sep 20161:42 pmRNSDirector/PDMR Shareholding
2nd Sep 20161:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.